title: Mevalonate kinase deficiency (hyper IgD syndrome with periodic fever)--different faces with separate treatments: two cases and review of the literature.
abstract: The hyperimmunoglobulinemia D syndrome (HIDS), so-called mevalonate kinase deficiency, is caused by recessive mutations in the gene encoding mevalonate kinase enzyme. HIDS is characterized by recurrent fever attacks of 3-7 days that begin in infancy and recur every 4-6 weeks. The febrile period is accompanied by lymphadenopathy, arthralgia, abdominal pain, diarrhea, aphthous ulcers, and varying degree of skin involvement. The course and severity of the disease may be quite different. There is no effective or proven therapy for HIDS. We report two cases with HIDS, which had separate clinical findings and treatment strategies.
authors.affiliation: Department of Pediatrics, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey. erbil.unsal@deu.edu.tr.
authors.forename: Pınar
authors.initials: P
authors.lastname: Gençpınar
authors.forename: Balahan B
authors.initials: BB
authors.lastname: Makay
authors.forename: Marco
authors.initials: M
authors.lastname: Gattorno
authors.forename: Francesco
authors.initials: F
authors.lastname: Caroli
authors.forename: Erbil
authors.initials: E
authors.lastname: Ünsal
mesh_terms: D002648:Child; D002675:Child, Preschool; D004247:DNA / Q000235:genetics; D004252:DNA Mutational Analysis; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D054078:Mevalonate Kinase Deficiency / Q000175:diagnosis / Q000201:enzymology / Q000628:therapy*; D009154:Mutation; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000097:blood* / Q000235:genetics; D012074:Remission Induction / Q000379:methods*
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D004247:DNA; D017853:Phosphotransferases (Alcohol Group Acceptor); C021796:mevalonate kinase